Main menu button

Actualités

Analysis, Oboya: Strong growth under the 2nd quarter
14 Août 2017
Analysis, Oboya: Strong growth under the 2nd quarter
Equity Research
Analysis, Serneke: Increasing values in Karlastaden
19 Juil 2017
Analysis, Serneke: Increasing values in Karlastaden
Equity Research
Earnings review: Serneke Q2 2017
19 Juil 2017
Earnings review: Serneke Q2 2017
Equity Research
Analysis, Lammhults: Business delayed until later this year
07 Juil 2017
Analysis, Lammhults: Business delayed until later this year
Equity Research
Analysis Sonetel: Focus on Growth
07 Juil 2017
Analysis Sonetel: Focus on Growth
Equity Research
Preview, Serneke: Q2, 2017
07 Juil 2017
Preview, Serneke: Q2, 2017
Equity Research
Analysis, FastPartner: Increased cash flow
06 Juil 2017
Analysis, FastPartner: Increased cash flow
Equity Research
Analysis, Maxkompetens: Cheap growth
04 Juil 2017
Analysis, Maxkompetens: Cheap growth
Equity Research
Analysis, Neurovive: NeuroVive sits on a stronger hand
28 Juin 2017
Analysis, Neurovive: NeuroVive sits on a stronger hand
Equity Research
Analysis, Spectracure: Clinical Study has started
19 Juin 2017
Analysis, Spectracure: Clinical Study has started
Equity Research
Analysis, Karolinska Development: Can Modus give new blood?
19 Juin 2017
Analysis, Karolinska Development: Can Modus give new blood?
Equity Research
Analysis, Brighter: Countdown to launch has begun
15 Juin 2017
Analysis, Brighter: Countdown to launch has begun
Equity Research
Analysis, Savosolar: New money for continued growth
14 Juin 2017
Analysis, Savosolar: New money for continued growth
Equity Research
13 Juin 2017
Analysis, Pharmacolog: New markets in sight
Equity Research
Analysis, Consilium: Stronger orderbook in April
29 Mai 2017
Analysis, Consilium: Stronger orderbook in April
Equity Research
Analysis, Gapwaves: New important NDA
29 Mai 2017
Analysis, Gapwaves: New important NDA
Equity Research
Analysis, Boule Diagnostics: Growth with speed
29 Mai 2017
Analysis, Boule Diagnostics: Growth with speed
Equity Research
Analysis, CLS: Important steps in the right direction
29 Mai 2017
Analysis, CLS: Important steps in the right direction
Equity Research
Analysis, Episurf: New cash for the future
29 Mai 2017
Analysis, Episurf: New cash for the future
Equity Research
Analysis, Genovis: New launch in focus
23 Mai 2017
Analysis, Genovis: New launch in focus
Equity Research